![who should avoid glp 1 GLP-1 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of GLP-1 Drugs and Eating Disorders:](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1050961973852737)
who should avoid glp 1
Shipping Estimate
who should avoid glp 1 GLP-1 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of GLP-1 Drugs and Eating Disorders:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
![who should avoid glp 1 GLP-1 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of GLP-1 Drugs and Eating Disorders:](https://www.c2st.org/wp-content/uploads/2026/01/GLP1Blog.png)
![who should avoid glp 1 GLP-1 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of GLP-1 Drugs and Eating Disorders:](https://www.perpetualwellbeing.com.au/wp-content/uploads/2025/12/glp-1-diet-plan.jpg)
![who should avoid glp 1 GLP-1 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of GLP-1 Drugs and Eating Disorders:](https://cdn.shopify.com/s/files/1/0072/7754/3493/files/limit-checklist.jpg?v=1777932644)
![who should avoid glp 1 GLP-1 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of GLP-1 Drugs and Eating Disorders:](https://media.self.com/photos/6973af3e2399cbaeb44f67f3/1:1/w_3000,h_3000,c_limit/why-im-not-taking-glp-1s.jpg)
